Allstate Corp Glaukos Corp Transaction History

Allstate Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$44.33 - $57.82 $454,072 - $592,250	-10,243 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$40.27 - $56.99 $148,717 - $210,464	3,693 Added 56.38%	10,243 $455,000
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $125,025 - $222,030	2,636 Added 67.35%	6,550 $316,000
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $55,525 - $74,252	-760 Reduced 16.26%	3,914 $332,000
Q1 2021 May 14, 2021	SELL	$70.43 - $97.42 $42,258 - $58,452	-600 Reduced 11.38%	4,674 $392,000
Q3 2020 Nov 13, 2020	BUY	$37.23 - $50.97 $196,351 - $268,815	5,274 New	5,274 $261,000

350

48M

282K

401K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.42B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.